Amur Minerals Corporation
CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed use… Read more
Amur Minerals Corporation - Asset Resilience Ratio
Amur Minerals Corporation (AMMCF) has an Asset Resilience Ratio of 12.83% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2020)
This chart shows how Amur Minerals Corporation's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Amur Minerals Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $998.39K | 12.83% |
| Total Liquid Assets | $998.39K | 12.83% |
Asset Resilience Insights
- Moderate Liquidity: Amur Minerals Corporation has 12.83% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Amur Minerals Corporation Industry Peers by Asset Resilience Ratio
Compare Amur Minerals Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Amur Minerals Corporation (2010–2020)
The table below shows the annual Asset Resilience Ratio data for Amur Minerals Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.00% | $3.00 | $32.40 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $26.38 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $29.32 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $29.63 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $23.52 Million | -- |
| 2014-12-31 | 34.94% | $7.38 Million | $21.12 Million | +7.55pp |
| 2013-12-31 | 27.39% | $8.22 Million | $30.03 Million | +5.40pp |
| 2012-12-31 | 21.99% | $5.79 Million | $26.32 Million | +4.42pp |
| 2010-12-31 | 17.57% | $3.81 Million | $21.66 Million | -- |